ACADIA Pharmaceuticals Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript
Good morning, everybody. Thanks for joining us at the, now, Virtual Bank of America Healthcare Conference. I'm Tazeen Ahmad, I'm one of the mid-biotech analysts here at the firm. It is my pleasure to introduce our next presenting company, ACADIA Pharmaceuticals. I have several members from ACADIA management here with me. Steve Davis, who is, of course, Chief Executive Officer; Michael Yang, Executive Vice President and Chief Commercial Officer; and Elena Ridloff, who is Chief Financial Officer.
Good morning, guys. Thanks so much for joining us today.
Thanks much, Tazeen, we're very pleased to participate in your conference.
So maybe, Steve, we have a few questions that we'd like to talk about as it relates to upcoming and recent events. But maybe you could just do a quick overview of the company's portfolio and catalyst to date,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |